Partnering with you in the early drug development studies, our scientists excel in suggesting early process improvements. These enhancements aim to reduce the number of transformations required to synthesize a given molecule and enhance the efficiency of these transformations.
Our laboratory services provide crucial support for implementation, enabling the preparation of scaled quantities of your target product to establish a continuous process. Additionally, we collaborate with your in-house team to design and construct process-scale reactors, ensuring a seamless technology transfer. Our state-of-the-art infrastructure includes a variety of reactors, such as Plug Flow reactors, Packed Bed reactors, Continuous Stirred-tank Reactors (CSTRs), Photoreactors, and Electrochemical reactors.
As molecules progress, we play a pivotal role in creating more cost-effective, robust, and safe processes for manufacturing the active pharmaceutical ingredient (API) for initial pilot batches and subsequently for commercial production.
Structured to oversee custom small-molecule process development from the early clinical phase to commercial production, we offer a flexible manufacturing landscape. With capacities ranging from small to large scale, we cater to customized solutions and ensure the seamless transfer of technologies.
Our development teams specialize in creative problem-solving for early-phase challenges while maintaining a focus on validation rigor. This approach helps you avoid late-stage process changes that could impact your speed to market, resulting in more efficient preparation of your APIs and intermediates and instilling greater confidence in the success of your project.
